PTPRC and neoplasm: In contrast to our previous findings in STING wild‐type tumor models, P2 treatment did not significantly alter the frequency of intratumoral immune (CD45+) and total T (CD3+) cell infiltration (Figure 7C,D), and CD4+ and CD8+ T cells (Figure 7E,F) in STING KO tumors.